Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковский Национальный Медицинский УниверситетfiledCriticalХарьковский Национальный Медицинский Университет
Priority to UAU201105727UpriorityCriticalpatent/UA64163U/ru
Publication of UA64163UpublicationCriticalpatent/UA64163U/ru
Investigating Or Analysing Biological Materials
(AREA)
Abstract
Способ прогнозирования развития хронического пиелонефрита у детей включает клинико-инструментальные обследования, биохимические исследования крови и мочи. Дополнительно в сыворотке крови и в моче определяют уровень α-2-макроглобулина в активную и неактивную фазу острого пиелонефрита.
UAU201105727U2011-05-062011-05-06Способ прогнозирования развития хронического пиелонефрита у детей
UA64163U
(ru)
Combinacion de anticuerpos anti-gen 3 de la activacion del linfoncito (lag-3) y anticuerpos anti-muerte celular programada 1 (pd-1) para usarse en el tratamiento de tumores.
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND THE PRODUCTION OF SUCCINATE CORRESPONDING
Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
BROWN ADIPOCYTES OBTAINED FROM PLURIPOTENTIAL STEM CELLS, CELL AGGRAIN OBTAINED FROM PLURIPOTENTIAL STEM CELLS, METHOD OF MANUFACTURE THEREOF, AND CELL THERAPY AND MEDICAL THERAPY THEREFOR
MASS TEST OF BLOOD CELL BLOOD CELLS USING CELL COAGULATION, ADULT BLOOD STEM CELLS USING THE SAME, METHOD OF EXPANDING PROGENITOR CELLS AND STEM CELLS PRODUCED USING THE METHOD